Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
<p><strong>Background </strong>Enteric fever is estimated to affect 11–20 million people worldwide each year. Morbidity and mortality from enteric fever primarily occur in lower-income countries, with children under 5 years of age experiencing a significant portion of the burden. O...
Auteurs principaux: | Theiss-Nyland, K, Shakya, M, Colin-Jones, R, Voysey, M, Smith, N, Karkey, A, Dongol, S, Pant, D, Farooq, Y, Neuzil, K, Shrestha, S, Basnyat, B, Pollard, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Oxford University Press
2019
|
Documents similaires
-
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
par: Shakya, M, et autres
Publié: (2019) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
par: Shakya, M, et autres
Publié: (2019) -
Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal
par: Colin-Jones, R, et autres
Publié: (2019) -
Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
par: Dahal, A, et autres
Publié: (2022) -
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age
par: Bijukchhe, SM, et autres
Publié: (2024)